IndieBio is the world’s largest biotechnology accelerator, and Proteorex presented as part of the Batch 5 Cohort. The company is is developing small molecule drugs for challenging targets implicated in diseases with the highest unmet need.
The presentation was delivered in San Francisco this September 14th by Dr. Marc Adler, Co-Founder and Technology Director of Proteorex.
For a video of the presentation click here